Stay updated with breaking news from Science Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PALM BEACH, Fla., March 31, 2022 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - Alzheimer's disease (AD) is an irreversible, progressive neurodegenerative disease. It is the most common
/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Alzheimer's disease (AD) is an irreversible, progressive neurodegenerative disease. It is the most...
/PRNewswire/ -- Atopic Dermatitis is an inflammatory skin disease, and the degree of its severity varies from patient to patient. It usually begins in...
FinancialNewsMedia.com News Commentary PALM BEACH, Fla., Oct. 12, 2021 /PRNewswire/ -- Atopic Dermatitis is an inflammatory skin disease, and the degree of its severity varies from patient
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Cassava Sciences Announces Significant Program Progress and Expected Key Milestones in 2021 for ... Cassava Sciences, Inc.February 8, 2021 GMT AUSTIN, Texas, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company developing product candidates for Alzheimer’s disease, today announced significant program progress and expected milestones for 2021. “We started 2021 with tremendous momentum, led by results of a 6-month interim analysis from an...